Shine a light on potential new treatments for RSV
This clinical trial may be right for you if you are an adult with confirmed RSV infection. If your age is between 18 and 64, you can participate if you have one or more of the following which increase the risk of RSV severity:
- A long-term lung disease
- Heart failure
- A condition that weakens the immune system
If you are 65 (+), you can participate even if you do not have any of these conditions listed above.
Qualified participants will receive:
- Study-related medication at no cost
- Study-related medical exams at no cost
- Compensation for time and travel
No insurance is needed to participate.
Contribute to the advancement of medical knowledge and treatments, while receiving expert medical care under close supervision.
The M3 Wake Research Network has powered innovation with over 9,100 Successful Clinical Trials in patients from 6 months to 85 years.
Patient safety is paramount with strict protocols and ethical guidelines, minimizing risks and ensuring thorough monitoring throughout the trial.